Dipyridamole-thallium/sestamibi before vascular surgery: A prospective blinded study in moderate-risk patients

Journal of Vascular Surgery

Volumn 32, Issue 1, 2000, Pages 77-89

  De Virgilio, Christian ^a   Toosie, Katayoun ^a   Ephraim, Linda ^a   Elbassir, Magdi ^a   Donayre, Carlos ^a   Baker, J Dennis ^b   Narahara, Kenneth ^a   Mishkin, Fred ^a   Lewis, Roger J ^a   Chang, Catherine ^a   White, Rodney ^a   Mody, Freny Vaghaiwalla ^b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; THALLIUM;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK FACTOR; SENESCENCE; VASCULAR SURGERY;

EID: 0034234260     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2000.107311     Document Type: Article

References (24)

1. Wackers F., Berman D., Maddahi J. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparisons to thallium-210 for myocardial perfusion imaging. J Nucl Med. 30:1989;301-311.
2. Meyer J., Mena I., Diggles L., Narahara K. Assessment of myocardial perfusion defect size after early and delayed SPECT imaging with technetium-99m hexakis 2-methoxyisobutly isonitrile after stress. J Nucl Med. 34:1993;187-192.
3. Boucher C., Wackers F., Zaret B., Mena I. Technetium-99m sestamibi myocardial imaging at rest for assessment of myocardial infarction and first-pass ejection fraction. Multicenter Cardiolite Study Group. Am J Cardiol. 69:1992;22-27.
4. Boucher C., Brewster D., Darling R. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med. 312:1985;389-394.
5. Eagle, KA, Coley, CM, Newell, J, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Int Med 1989; 100:859-66
6. Cutler B., Leppo A. Dipyridamole thallium 201 scintigraphy to detect coronary artery disease before abdominal aortic surgery. J Vasc Surg. 5:1987;91-99.
7. Cambria R., Brewster D., Abbott W. The impact of selective use of dipyridamole-thallium scans and surgical factors on the current morbidity of aortic surgery. J Vasc Surg. 15:1992;43-51.
8. Brewster D., Okada R., Strauss W. Selection of patients for preoperative coronary angiography: use of dipyridamole-stress thallium myocardial imaging. J Vasc Surg. 2:1985;504-509.
9. Lette J., Waters D., Lassonde J. Postoperative myocardial infarction and cardiac death: predictive value of dipyridamole-thallium and five clinical scoring systems based on multifactorial analysis. Ann Surg. 211:1990;84-90.
10. Lette J., Lassonde J. Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction. J Vasc Surg. 14:1991;160-169.
11. Leppo J., Plaja J., Gionet M. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol. 9:1987;269-276.
12. Vanzetto G., Machecourt J., Blendea D. Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am J Cardiol. 77:1996;143-148.
13. de Virgilio C., Pak S., Arnell T. Cardiac assessment prior to vascular surgery: is dipyridamole-sestamibi necessary? Ann Vasc Surg. 10:1996;325-329.
14. de Virgilio C., Kirby L., Lewis R. Limited utility of dipyridamole-thallium for predicting adverse events after vascular surgery. Vasc Surg. 32:1998;275-280.
15. Baron J., Mundler O., Bertrand M. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med. 330:1994;663-669.
16. Mangano D., London M., Tubau J. Dipyridamole thallium-201 scintigraphy as a preoperative screening test: a reexamination of its predictive potential. Circulation. 84:1991;493-502.
17. Stratmann H., Younis L., Wittry M. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events. Am Heart J. 131:1995;923-929.
18. Seeger J., Rosenthal G., Self S. Does routine stress-thallium cardiac screening reduce postoperative cardiac complications? Ann Surg. 6:1994;654-663.
19. Taylor L.M., Yeager R.A., Moneta G. The incidence of perioperative myocardial infarction in general vascular surgery. J Vasc Surg. 1992;15.
20. Fintel D., Links J., Brinker J. Improved diagnostic performance of exercise thallium 201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis. J Am Coll Cardiol. 13:1989;600-612.
21. Krupski W., Layug E., Reilly L. Comparison of cardiac morbidity between aortic and infrainguinal operations. J Vasc Surg. 15:1992;354-365.
22. Massie M.T., Michael J. Rohrer, et al. Is coronary angiography necessary for vascular surgery patients who have positive results of dipyridamole thallium scans? J Vasc Surg. 25:1997;975-983.
23. Hertzer N., Beven E., Young J. Coronary artery disease in peripheral vascular patients: a classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 199:1984;223-233.
24. Bry J.D.L., Belkin M., O'Donnell T. An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery. J Vasc Surg. 11:1994;497-504.